compounds in the body that activate these receptors, and the creation of synthetic compounds that also activate cannabinoid receptors. Chapter 12 discusses the Institute of Medicine's recommendations—as well as those of other expert organizations—for building on these findings as we contemplate the future of marijuana-based medicine.